Ohio State Cancer Center /ID# 203131 — Columbus, Ohio

Ohio State Cancer Center /ID# 203131 is a clinical research site located in Columbus, Ohio, United States 43210.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Ohio State Cancer Center /ID# 203131 has participated in 1 clinical trials.

Therapeutic areas: Exocrine Pancreatic Insufficiency (EPI).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ohio State Cancer Center /ID# 203131?

Ohio State Cancer Center /ID# 203131 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ohio State Cancer Center /ID# 203131 conducted?

Ohio State Cancer Center /ID# 203131 has 1 clinical trials on record. Their work covers Exocrine Pancreatic Insufficiency (EPI).

Is Ohio State Cancer Center /ID# 203131 accredited by Crixeo Health?

Ohio State Cancer Center /ID# 203131 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ohio State Cancer Center /ID# 203131?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.